Aster DM Healthcare

Aster DM Healthcare delivered robust quarterly results with revenue growing 8% year-on-year to INR 1,078 crores and operating EBITDA expanding 21% to INR 215 crores, achieving a 20% margin. Normalized PAT increased 22% to INR 90 crores. The Kerala cluster showed recovery with 5% revenue growth after previous quarter's 4% decline, driven by 6% sequential increase in patient volumes and 12% jump in medical value travel revenues. ARPOB registered strong 14% year-on-year growth, supported by reduced average length of stay and higher oncology contributions. The company added over 300 beds, bringing total capacity to 5,197 beds, with plans to add another 2,600 beds. The proposed merger with Quality Care India Limited progressed with shareholder approvals and Competition Commission clearance. QCIL reported 16% revenue growth to INR 1,079 crores with 19% EBITDA growth. The combined entity would operate over 10,350 beds across 38 hospitals in 27 cities. Aster Labs showed turnaround with EBITDA margins improving from 3.4% to 7.6%. The company maintained strong liquidity with INR 1,455 crores in cash and cash equivalents while gross debt remained at INR 643 crores. ROCE improved significantly from 16.5% to 20.7%.

Aster DM Healthcare Limited appointed Mr. Sudeep Dey as Chief Information Officer & Chief Information Security Officer, effective August 01, 2025, on a full-time employment basis. Dey brings over 25 years of experience in enterprise IT, business process reengineering, and AI-driven healthcare solutions. He previously served as President IT & CIO at Healthcare Global Enterprises (HCG), leading digital transformation and clinical IT innovation. His career includes leadership roles at Fortis Healthcare, Godfrey Phillips, and Oracle Financial Services. Dey holds a graduate degree in Physics from Ch. Charan Singh University and a PGDBA in Finance from Symbiosis, along with certifications from Harvard, Stanford, Johns Hopkins, and the University of Pennsylvania in AI, digital transformation, risk & compliance, and fintech. He has received top CIO awards and specializes in cybersecurity, enterprise automation, and healthcare IT innovations.

Aster DM has set a target to achieve ₹1,000 crore EBITDA in its India business by FY27. The company expects to generate over ₹1,500 crore in free cash flow following its GCC deal. The healthcare company is expanding operations through increased bed additions and pharma retail expansion. Aster DM is also pursuing strategic mergers and acquisitions in profitable healthcare segments.